XML 45 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Quarterly Results (unaudited)
 1 Months Ended
Apr. 30, 2020
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Results (unaudited) Quarterly Results (unaudited)
Quarterly results are determined in accordance with the accounting policies used for annual data and include certain items based upon estimates for the entire year. All fiscal quarters presented include results for 13 weeks.
Quarter Ended
April 24, 2021January 23, 2021October 24, 2020July 25, 2020
Net sales$1,561,793 $1,551,268 $1,553,168 $1,245,837 
Gross profit304,405 324,541 320,368 253,816 
Operating income (loss)37,348 61,681 73,706 37,872 
Net income (loss)28,514 48,567 53,826 24,202 
Net loss attributable to noncontrolling interests(241)(192)(234)(205)
Net income (loss) attributable to Patterson Companies, Inc.$28,755 $48,759 $54,060 $24,407 
Earnings (loss) per share attributable to Patterson Companies, Inc.:
Basic$0.30 $0.51 $0.57 $0.26 
Diluted$0.30 $0.50 $0.56 $0.25 
Quarter Ended
April 25, 2020 (1)
January 25, 2020
October 26, 2019 (2)
July 27, 2019 (3)
Net sales$1,286,461 $1,456,155 $1,418,744 $1,328,651 
Gross profit294,032 311,830 301,494 290,054 
Operating income (loss)(614,463)43,816 (18,146)16,674 
Net income (loss)(608,797)22,972 (33,349)29,807 
Net loss attributable to noncontrolling interests(211)(255)(220)(235)
Net income (loss) attributable to Patterson Companies, Inc.$(608,586)$23,227 $(33,129)$30,042 
Earnings (loss) per share attributable to Patterson Companies, Inc.:
Basic$(6.44)$0.25 $(0.35)$0.32 
Diluted$(6.44)$0.24 $(0.35)$0.32 
(1)In the fourth quarter of fiscal 2020, we recorded goodwill impairment charges totaling $675,055 in our Animal Health segment. See Note 1 for additional information. In addition, the COVID-19 virus had a significant impact on our businesses in the fourth quarter of fiscal 2020. Through March 2020, sales in our Dental and Animal Health segments were up year over year. In April 2020, our Dental segment sales were down approximately 71% and our Animal Health segment sales were down approximately 9%, as compared to April 2019. In addition, operating expenses were also down significantly in April 2020 as certain variable expenses decreased with sales.
(2)We incurred costs and expenses of $58,300 during the second quarter of fiscal 2020 related to the then-probable settlement of an investigation by the U.S. Attorney's Office for the Western District of Virginia.
(3)We recorded a pre-tax gain of $34,334 related to one of our investments during the first quarter of fiscal 2020. This gain was based on the selling price of preferred stock in this investment that is similar to the preferred stock we own, and was adjusted for differences in liquidation preferences. In addition, we incurred expenses of $17,666 during the first quarter of fiscal 2020 related to the settlement of litigation with SourceOne Dental, Inc.